BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2164618)

  • 1. Stromal neoplasms of the breast: a comparative flow cytometric study.
    El-Naggar AK; Mackay B; Sneige N; Batsakis JG
    J Surg Oncol; 1990 Jul; 44(3):151-6. PubMed ID: 2164618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between DNA ploidy and the clinical behavior of phyllodes tumors.
    Layfield LJ; Hart J; Neuwirth H; Bohman R; Trumbull WE; Giuliano AE
    Cancer; 1989 Oct; 64(7):1486-9. PubMed ID: 2550124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA content and proliferative activity of cystosarcoma phyllodes of the breast. Potential prognostic significance.
    el-Naggar AK; Ro JY; McLemore D; Garnsy L
    Am J Clin Pathol; 1990 Apr; 93(4):480-5. PubMed ID: 2157332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructure of cystosarcoma phyllodes and fibroadenoma. A comparative study.
    Yeh IT; Francis DJ; Orenstein JM; Silverberg SG
    Am J Clin Pathol; 1985 Aug; 84(2):131-6. PubMed ID: 2992265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal analysis of fibroadenoma and phyllodes tumor of the breast.
    Noguchi S; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer Res; 1993 Sep; 53(17):4071-4. PubMed ID: 8395336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sarcomas originating in breast fibroadenomas (cystosarcoma phyllodes, malignant form). Considerations on 28 cases].
    da Silva Neto JB; Giannotti Filho O
    AMB Rev Assoc Med Bras; 1979 Mar; 25(3):108-10. PubMed ID: 228358
    [No Abstract]   [Full Text] [Related]  

  • 7. Flow cytometric S fraction as a predictor of clinical outcome in cystosarcoma phyllodes.
    Palko MJ; Wang SE; Shackney SE; Cottington EM; Levitt SB; Hartsock RJ
    Arch Pathol Lab Med; 1990 Sep; 114(9):949-52. PubMed ID: 2167652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystosarcoma phyllodes of the breast: histologic features, flow cytometric analysis, and clinical correlations.
    Grimes MM
    Mod Pathol; 1992 May; 5(3):232-9. PubMed ID: 1323101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric DNA content analysis of 185 soft tissue neoplasms indicates that S-phase fraction is a prognostic factor for sarcomas. French Federation of Cancer Centers (FNCLCC) Sarcoma Group.
    Collin F; Chassevent A; Bonichon F; Bertrand G; Terrier P; Coindra JM
    Cancer; 1997 Jun; 79(12):2371-9. PubMed ID: 9191525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic findings in phyllodes tumor and fibroadenomas of the breast.
    Barbosa ML; Ribeiro EM; Silva GF; Maciel ME; Lima RS; Cavalli LR; Cavalli IJ
    Cancer Genet Cytogenet; 2004 Oct; 154(2):156-9. PubMed ID: 15474152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases.
    Niezabitowski A; Lackowska B; Rys J; Kruczak A; Kowalska T; Mitus J; Reinfuss M; Markiewicz D
    Breast Cancer Res Treat; 2001 Jan; 65(1):77-85. PubMed ID: 11245343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phyllodes tumors of the breast: correlation of nucleolar organizer regions with histopathological malignancy grading, flow cytometric DNA analysis and clinical outcome.
    Samaratunga H; Clarke B; Owen L; Bryson G; Swanson C
    Pathol Int; 2001 Nov; 51(11):866-73. PubMed ID: 11844053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroadenoma and cystosarcoma phyllodes of the male breast.
    Ansah-Boateng Y; Tavassoli FA
    Mod Pathol; 1992 Mar; 5(2):114-6. PubMed ID: 1315437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular assessment of clonality leads to the identification of a new germ line TP53 mutation associated with malignant cystosarcoma phyllodes and soft tissue sarcoma.
    Bot FJ; Sleddens HF; Dinjens WN
    Diagn Mol Pathol; 1998 Dec; 7(6):295-301. PubMed ID: 10207667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical aspects in the diagnosis and management of cystosarcoma phyllodes.
    Hart J; Layfield LJ; Trumbull WE; Brayton D; Barker WF; Giuliano AE
    Arch Surg; 1988 Sep; 123(9):1079-83. PubMed ID: 2843145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flow cytometric analysis of DNA from 98 cases of soft tissue tumors and its clinical significance].
    Li S
    Zhonghua Wai Ke Za Zhi; 1990 May; 28(5):281-4, 318. PubMed ID: 2086097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric nuclear DNA content of fresh and paraffin-embedded tissues of breast carcinomas and fibroadenomas.
    De Vita R; Calugi A; Eleuteri P; Maggi O; Nassuato C; Vecchione A
    Eur J Basic Appl Histochem; 1991; 35(3):233-44. PubMed ID: 1718443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcomas of the Breast with a Spotlight on Angiosarcoma and Cystosarcoma Phyllodes.
    Thornton K
    Surg Oncol Clin N Am; 2016 Oct; 25(4):713-20. PubMed ID: 27591494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phyllodes tumor: clinicopathologic review of 60 patients and flow cytometric analysis in 30 patients.
    Keelan PA; Myers JL; Wold LE; Katzmann JA; Gibney DJ
    Hum Pathol; 1992 Sep; 23(9):1048-54. PubMed ID: 1325408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubular carcinoma developing within a recurring cystosarcoma phyllodes of the breast.
    Leong AS; Meredith DJ
    Cancer; 1980 Oct; 46(8):1863-7. PubMed ID: 6253046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.